Dual treatment of albendazole in hepatic hydatidosis: New therapeutic modality in 52 cases


Polat C., Dervisoglu A., Hokelek M., Yetim I., Buyukkarabacak Y., Ozkutuk Y., ...More

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol.20, no.3, pp.421-425, 2005 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 3
  • Publication Date: 2005
  • Doi Number: 10.1111/j.1440-1746.2004.03535.x
  • Title of Journal : JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  • Page Numbers: pp.421-425

Abstract

Background: Hepatic hydatidosis still remains as a serious problem in general surgery. Recurrence and/or secondary hydatidosis rates are up to 25% in the cases treated with surgery alone. Albendazole is the most commonly used drug in the medical treatment of echinococcosis. The aim of the present study was to evaluate the effect of albendazole using the intraoperative and perioperative periods as dual therapy.